Lyophilization Services for Biopharmaceuticals Market Opportunities and Strategies to 2033

This report describes and explains the lyophilization services for biopharmaceuticals market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global lyophilization services for biopharmaceuticals market reached a value of nearly $1.64 billion in 2023, having grown at a compound annual growth rate (CAGR) of 9.91% since 2018. The market is expected to grow from $1.64 billion in 2023 to $2.71 billion in 2028 at a rate of 10.50%. The market is then expected to grow at a CAGR of 11.15% from 2028 and reach $4.6 billion in 2033.

Growth in the historic period resulted from the increased demand for vaccines and antibodies, increased focus on personalized medicine, growing focus on clinical trials and increased demand for pharmaceutical products. Factors that negatively affected growth in the historic period include risk of contamination during the lyophilization process.

Going forward, the rising healthcare expenditure globally, growing incidence of chronic diseases, growing biopharmaceutical industry, increasing government initiatives, rise in drug approvals and investments in biopharmaceutical research and development will drive the market. Factors that could hinder the growth of the lyophilization services for biopharmaceuticals market in the future include expensive equipment and operational costs and shortage of skilled professionals.

The lyophilization services for biopharmaceuticals market is segmented by type into product and cycle development, clinical manufacturing, commercial manufacturing and freeze drying analytical services. The commercial manufacturing market was the largest segment of the lyophilization services for biopharmaceuticals market segmented by type, accounting for 35.10% or $23.64 million of the total in 2023. Going forward, the commercial manufacturing segment is expected to be the fastest growing segment in the lyophilization services for biopharmaceuticals market segmented by type, at a CAGR of 13.86% during 2023-2028.

The lyophilization services for biopharmaceuticals market is segmented by type of primary packaging system into vials, syringes, cartridges and other primary packaging systems. The vials market was the largest segment of the lyophilization services for biopharmaceuticals market segmented by type of primary packaging system, accounting for 64.86% or $43.68 million of the total in 2023. Going forward, the syringes segment is expected to be the fastest growing segment in the lyophilization services for biopharmaceuticals market segmented by type of primary packaging system, at a CAGR of 18.63% during 2023-2028.

The lyophilization services for biopharmaceuticals market is segmented by application into pharmaceutical and biotechnology companies, research institutes and other applications. The pharmaceutical and biotechnology companies market was the largest segment of the lyophilization services for biopharmaceuticals market segmented by application, accounting for 68.64% or $46.22 million of the total in 2023. Going forward, the research institutes segment is expected to be the fastest growing segment in the lyophilization services for biopharmaceuticals market segmented by application, at a CAGR of 13.62% during 2023-2028.

North America was the largest region in the lyophilization services for biopharmaceuticals market, accounting for 34.62% or $570.8 million of the total in 2023. It was followed by Western Europe, Asia-Pacific and then the other regions. Going forward, the fastest-growing regions in the lyophilization services for biopharmaceuticals market will be Asia-Pacific and Africa, where growth will be at CAGRs of 12.72% and 12.27% respectively. These will be followed by the Middle East and South America, where the markets are expected to grow at CAGRs of 11.98% and 11.18% respectively.

The global lyophilization services for biopharmaceuticals market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 24.64% of the total market in 2023. PCI Pharma Services was the largest competitor with a 4.09% share of the market, followed by OFD LLC (Oregon Freeze Dry) with 3.82%, Simtra BioPharma Solutions (Baxter) with 3.48%, Vetter Pharma-Fertigung GmbH & Co. KG with 3.31%, IDT Biologika GmbH with 2.70%, Jubilant HollisterStier Inc with 1.99%, Curia Global Inc with 1.70%, CinnaGen with 1.51%, CordenPharma with 1.16% and Ascendia Pharmaceuticals with 0.88%.

The top opportunities in the lyophilization services for biopharmaceuticals market segmented by type will arise in the commercial manufacturing segment, which will gain $434.8 million of global annual sales by 2028. The top opportunities in the lyophilization services for biopharmaceuticals market segmented by type of primary packaging system will arise in the vials segment, which will gain $545.35 million of global annual sales by 2028. The top opportunities in the lyophilization services for biopharmaceuticals market segmented by application will arise in the pharmaceutical and biotechnology companies segment, which will gain $745.69 million of global annual sales by 2028. The lyophilization services for biopharmaceuticals market size will gain the most in the USA at $272.75million.

Market-trend-based strategies for the lyophilization services for biopharmaceuticals market include focus on introduction of advanced laboratory freeze dryers enhancing research efficiency, expansion of commercial-scale aseptic filling facilities to enhance bioconjugate production capabilities, strategic partnerships and collaborations among major players and investment in freeze-drying infrastructure to support biopharmaceutical industry growth.

Player-adopted strategies in the lyophilization services for biopharmaceuticals market include focus on strengthening business operations through facility expansions, strategic investments and strategic partnerships.

To take advantage of the opportunities, the analyst recommends the lyophilization services for biopharmaceuticals companies to focus on expanding advanced laboratory freeze dryer capabilities, focus on expanding commercial-scale aseptic filling facilities, focus on commercial manufacturing segment, focus on syringes segment, expand in emerging markets, focus on strategic partnerships to enhance lyophilization capabilities, focus on expanding production facilities for enhanced freeze-drying capabilities, focus on enhancing distribution channels for lyophilization services, provide competitively priced offerings, continue to use B2B promotions, focus on leveraging industry conferences for promotion and focus on research institutes.